Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to Gliclazide
Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
The investigators set up a clinical trial to compare effect of dapagliflozin, a sodium
glucose co-transporter 2 inhibitor, with gliclazide on vascular function in patients with
type 2 diabetes